R Chibbar Selected Research

Immunotherapy

10/2013

Potent CD4+ T-cell epitope P30 enhances HER2/neu-engineered dendritic cell-induced immunity against Tg1-1 breast cancer in transgenic FVBneuN mice by enhanced CD4+ T-cell-stimulated CTL responses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

R Chibbar Research Topics

Disease

2	Neoplasms (Cancer) 10/2013 - 08/2009
1	Breast Neoplasms (Breast Cancer) 10/2013
1	Melanoma (Melanoma, Malignant) 10/2013
1	Acute Kidney Injury (Acute Renal Failure) 06/2013
1	Hemorrhage 08/2009

Drug/Important Bio-Agent (IBA)

1	AntigensIBA 10/2013
1	ErbB Receptors (EGF Receptor)IBA 10/2013
1	VaccinesIBA 10/2013
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 10/2013
1	Trastuzumab (Herceptin)FDA Link 10/2013
1	Intravenous Immunoglobulins (IVIG)FDA Link 06/2013

Therapy/Procedure

1	Immunotherapy 10/2013
1	Renal Dialysis (Hemodialysis) 06/2013
1	Gastrectomy 08/2009